Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of the National Cancer Institute|June 17, 2024
Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysisXianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Molecular Cancer|June 8, 2023
Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical TrialsXianjing Chu, Wentao Tian, Ziqi Wang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 27, 2025
Immunotherapy may promote the occurrence of radiation-induced brain injury in NSCLC patients with brain metastases undergoing radiotherapy: a retrospective propensity score-matching and inverse probability of treatment weighting studySai Li, JingYi Tang, Ruiting Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 22, 2025
Predicting Survival Rates in Brain Metastases Patients from Non-Small Cell Lung Cancer Using Radiomic Signatures Associated with Tumor Immune HeterogeneityFuxing Deng, Gang Xiao, Guilong Tanzhu, et al.
CNS Neuroscience & Therapeutics|November 5, 2024
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective AnalysisQian Zeng, Xianjing Chu, Gang Xiao, et al.
Iscience|September 4, 2023
Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trialXianjing Chu, Lishui Niu, Xianghui Yang, et al.
Physical and Engineering Sciences in Medicine|July 17, 2023
MRI radiomics for brain metastasis sub-pathology classification from non-small cell lung cancer: a machine learning, multicenter studyFuxing Deng, Zhiyuan Liu, Wei Fang, et al.
Pageof 2